| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.002 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |